Septerna (NASDAQ:SEPN) Given New $65.00 Price Target at Guggenheim

Septerna (NASDAQ:SEPN) had its target price hoisted by equities researchers at Guggenheim from $51.00 to $65.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim‘s target price would suggest a potential upside of 32.79% from the stock’s current price.

Several other brokerages also recently issued reports on SEPN. HC Wainwright upped their target price on shares of Septerna from $40.00 to $60.00 and gave the stock a “buy” rating in a research note on Wednesday, August 12th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Septerna in a report on Thursday, October 15th. JPMorgan Chase & Co. raised their price target on shares of Septerna from $38.00 to $48.00 and gave the company an “overweight” rating in a research report on Wednesday, August 19th. Raymond James Financial restated a “strong-buy” rating and issued a $49.00 price objective on shares of Septerna in a report on Tuesday, August 11th. Finally, JonesTrading upped their price objective on Septerna from $43.00 to $62.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $55.22.

Septerna Trading Up 3.4%

Shares of SEPN stock traded up $1.60 during midday trading on Friday, reaching $48.95. 29,031 shares of the stock were exchanged, compared to its average volume of 362,267. Septerna has a 1 year low of $17.55 and a 1 year high of $51.10. The company’s 50 day moving average is $39.36 and its two-hundred day moving average is $32.48. The firm has a market cap of $2.28 billion, a PE ratio of -91.07 and a beta of 2.20.

Septerna (NASDAQ:SEPN) last issued its quarterly earnings results on Monday, August 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.14. Septerna had a negative net margin of 24.51% and a negative return on equity of 9.57%. The company had revenue of $26.75 million during the quarter, compared to analyst estimates of $19.22 million. As a group, equities analysts expect that Septerna will post -1.41 EPS for the current fiscal year.

Insider Buying and Selling

In other Septerna news, COO Elizabeth Bhatt sold 25,000 shares of Septerna stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $44.00, for a total value of $1,100,000.00. Following the sale, the chief operating officer directly owned 174,209 shares in the company, valued at approximately $7,665,196. The trade was a 12.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Daniel D. Long sold 3,333 shares of the company’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $37.83, for a total value of $126,087.39. Following the sale, the senior vice president directly owned 96,412 shares in the company, valued at $3,647,265.96. This trade represents a 3.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 32,333 shares of company stock valued at $1,375,727. 5.80% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Covestor Ltd raised its stake in shares of Septerna by 19.0% in the third quarter. Covestor Ltd now owns 2,526 shares of the company’s stock valued at $98,000 after acquiring an additional 403 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Septerna in the 3rd quarter worth about $93,000. Profund Advisors LLC bought a new stake in shares of Septerna in the 3rd quarter worth about $1,497,000. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its holdings in shares of Septerna by 24.8% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 16,600 shares of the company’s stock worth $650,000 after acquiring an additional 3,300 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its stake in shares of Septerna by 12.5% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 12,117 shares of the company’s stock worth $474,000 after purchasing an additional 1,343 shares during the period.

About Septerna

Septerna, Inc is a clinical-stage biotechnology company focused on discovering and developing oral small-molecule medicines that target G protein-coupled receptors (GPCRs). GPCRs are a large class of cell-surface proteins involved in a wide range of biological processes and represent an important source of potential drug targets.

The company’s research is powered by its Native State platform, which is designed to study GPCRs in their natural biological configuration and support the discovery of selective small-molecule compounds.